Canna~Fangled Abstracts

Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat Schizophrenia

By August 8, 2022No Comments

doi: 10.1007/978-3-030-97182-3_7.



Schizophrenia is a psychiatric disorder of neurodevelopmental origin that is thought to result from the combination of genetic and socioenvironmental factors. Several studies have linked the endocannabinoid system with the pathophysiology of schizophrenia. Here, we provide a brief overview of the role of the endocannabinoid system (ECS) in the context of biological processes relevant to schizophrenia, such as neurodevelopment, synaptic plasticity, and brain energy metabolism. We also discuss alterations related to the ECS in schizophrenia and current efforts in both in vivo and in vitro studies that have provided a better understanding of the functioning of this system in the context of the disorder. Finally, we highlighted the modulation of the ECS as a potential for discovering novel therapeutic targets, suggesting new avenues for future research in the field.

Keywords: Animal models, Cannabidiol, Cannabinoids, Cell culture, Schizophrenia

Similar articles


    1. Abel, T., & Nickl-Jockschat, T. (Eds.). (2016). The neurobiology of schizophrenia. Academic Press.
    1. Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve-Roperh, I. (2005). The endocannabinoid system drives neural progenitor proliferation. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 19(12), 1704–1706. – DOI
    1. Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve-Roperh, I. (2006). The endocannabinoid system promotes Astroglial differentiation by acting on neural progenitor cells. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(5), 1551–1561. – DOI
    1. Barrera-Conde, M., Ausin, K., Lachén-Montes, M., Fernández-Irigoyen, J., Galindo, L., Cuenca-Royo, A., Fernández-Avilés, C., et al. (2021). Cannabis use induces distinctive proteomic alterations in olfactory Neuroepithelial cells of schizophrenia patients. Journal of Personalized Medicine, 11(3).
    1. Basavarajappa, B. S. (2007). Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. Current Neuropharmacology, 5(2), 81–97. – PubMed – PMC – DOI

LinkOut – more resources

Leave a Reply

en English